FDA Inspection
MD Tox LaboratoryMD Tox Laboratory – FDA Inspection, Jul 20, 2023
Record Details
This FDA Inspection record concerns MD Tox Laboratory, with an inspection on July 20, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a2e28a2c-4197-45a0-aed5-d3454a901e77
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1210547
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
14- 21 CFR 1271.160(a)All core requirements covered in program
- 21 CFR 1271.190(a)Size, construction, location--prevent mix-ups etc.
- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.270(a)Records incomplete
- 21 CFR 1271.270(d)Retention time (10 year rules)
- 21 CFR 1271.80(c)Manufacturer instructions not followed
- 21 CFR 1271.160(d)Computer software verification
- 21 CFR 1271.160(a)All core requirements covered in program
- 21 CFR 1271.160(d)Computer software verification
- 21 CFR 1271.180(a)Procedures to meet core CTGP
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MD Tox Laboratory
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 28, 2025 | VAI | Los Angeles District Office | Human Cellular, Tissue, and Gene Therapies |
| July 11, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for MD Tox Laboratory
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.